Advertisement
Canada markets close in 4 hours 5 minutes

  • S&P/TSX

    21,935.61
    +50.23 (+0.23%)
     

  • S&P 500

    5,101.05
    +52.63 (+1.04%)
     

  • DOW

    38,231.16
    +145.36 (+0.38%)
     

  • CAD/USD

    0.7311
    -0.0012 (-0.17%)
     

  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     

  • Bitcoin CAD

    86,849.20
    -836.56 (-0.95%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.96%)
     

  • GOLD FUTURES

    2,348.20
    +5.70 (+0.24%)
     

  • RUSSELL 2000

    1,994.15
    +13.03 (+0.66%)
     

  • 10-Yr Bond

    4.6630
    -0.0430 (-0.91%)
     

  • NASDAQ

    15,928.67
    +316.91 (+2.03%)
     

  • VOLATILITY

    15.44
    +0.07 (+0.46%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6836
    +0.0015 (+0.22%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

PRESS DIGEST- New York Times business news - May 4

Reuters
·1 min read

May 4 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

- The Federal Trade Commission (FTC) escalated its fight with the tech industry's biggest companies as it moved to impose what it called a "blanket prohibition" on the collection of young people's personal data by Meta Platforms Inc.

- The U.S. Senate voted on Wednesday to reinstate tariffs on solar panels from Chinese companies in Southeast Asia that had been found to be coming into the United States in violation of trade rules.

- Drug manufacturer Eli Lilly and Co announced that a clinical trial of an experimental Alzheimer's drug showed it can slow progress of the feared disease and allow patients to have more time when they can still live independently.

- The Food and Drug Administration (FDA) approved GSK Plc's vaccine for the respiratory syncytial virus, or R.S.V., for adults who are 60 and older, the company said. (Compiled by Bengaluru newsroom)